BillTracker

Bill: HB 2304 (SB 6506) — 2018

Concerning improving diversity in clinical trials (Lovick)

Seeks to increase diversity and representation in clinical trials by improving data and identifying barriers to participation. The Washington state review board will establish a diversity in clinical trials program to encourage participation in clinical trials of drugs and medical devices by persons who are members of demographic groups that are underrepresented in clinical trials.